Electra Therapeutics prices $350 million IPO, sets Nasdaq listing under ETRASep 18FinancingElectra Therapeutics Inc.
Electra Therapeutics files for IPO to fund lead antibody in blood disorder sHLHAug 28FinancingElectra Therapeutics Inc.
Sign in